Ethema Health (GRST) Stock Price, News & Analysis

Company Overview

Ethema Health Corporation operates behavioral healthcare space specifically in the treatment of substance use disorders. It offers rehabilitation services. The company was formerly known as GreeneStone Healthcare Corporation and changed its name to Ethema Health Corporation in April 2017. Ethema Health Corporation is based in West Palm Beach, Florida.

Key Stats

• Today's Range: $0.0004 to $0.0005
• 50-Day Range: N/A
• 52-Week Range: $0.0003 to $0.0010
• Volume: 18.92 million shs
• Average Volume: 9.47 million shs
• Market Capitalization: $3.86 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

GRST Stock Analysis - Frequently Asked Questions

How have GRST shares performed this year?

Ethema Health's stock was trading at $0.0007 at the beginning of the year. Since then, GRST stock has decreased by 28.6% and is now trading at $0.0005.
View the best growth stocks for 2025 here.

How do I buy shares of Ethema Health?

Shares of GRST stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Ethema Health own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Ethema Health investors own include Hemp (HEMP), Viva Entertainment Group (OTTV), NOHO (DRNK), HempAmericana (HMPQ), IFAN Financial (IFAN), Marijuana Company of America (MCOA) and Meta Platforms (META).

Company Calendar

• Today: 2/23/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: General medical & surgical hospitals
• Sub-Industry: Healthcare
• Current Symbol: OTCMKTS:GRST
• CUSIP: N/A
• CIK: 792935
• Web: ethemahealth.com
• Phone: (416) 500-0020
• Fax: N/A
• Employees: 50
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $1.18 million
• Net Margins: -2.31%
• Pretax Margin: -47.65%
• Return on Equity: -43.73%
• Return on Assets: -1.10%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.06
• Quick Ratio: 0.06

Sales & Book Value

• Annual Sales: $5.34 million
• Price / Sales: 0.72
• Cash Flow: $0.00 per share
• Price / Cash Flow: 0.51
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 7,726,280,000
• Free Float: 3,418,881,000
• Market Cap: $3.86 million
• Optionable: Not Optionable
• Beta: 2.32